Description
GABAPENTIN 300MG CAP 500 COUNT
First action · last action
2018-06-05 · 2018-06-05
Transactions
1
First transaction's obligation
$714,352
Base + all options value (sum of deltas)
$714,352
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
10
SDVOSB flag on record
Yes (self-representation)
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-06-05+$714,352= $714,352
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-06-05 | +$714,352 | $714,352 | GABAPENTIN 300MG CAP 500 COUNT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH6MV8JHYVL5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26126P1127 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · N059 · INSTALLATION OF EQUIPMENT- ELECTRICAL AND ELECTRONIC EQUIPMENT COMPONENTS | $48,365 | FY2026 |
| 36C26326N0598 | NETWORK CONTRACT OFFICE 23 (36C263) · Q517 · PHARMACY SERVICES | $26,550 | FY2026 |
| 36C77026P0057 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $8,436 | FY2026 |
| 36C77026P0056 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $61,011 | FY2026 |
| 36C26325N0710 | NETWORK CONTRACT OFFICE 23 (36C263) · Q517 · PHARMACY SERVICES | $22,500 | FY2025 |
| 36C26325D0074 | NETWORK CONTRACT OFFICE 23 (36C263) · Q517 · PHARMACY SERVICES | $0 | FY2025 |
Other recipients under 6505 from NATIONAL CMOP OFFICE (36C770) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C77026P0118 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $30,935 | FY2026 |
| 36C77026P0129 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $76,656 | FY2026 |
| 36C77026P0127 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $58,395 | FY2026 |
| 36C77026P0086 | SAGENT PHARMACEUTICALS, INC | NATIONAL CMOP OFFICE (36C770) | $275,580 | FY2026 |
| 36C77026P0095 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $83,520 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77018P1328_3600_-NONE-_-NONE- · retrieved 2026-09-26.